Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

Vialek Book Banner

Pierre Fabre SA and Puma Biotechnology Broadened License Agreement on Nerlynx®

Pierre Fabre SA and Puma Biotechnology, Inc. have broadened the geographic coverage of their license agreement on commercialisation of Nerlynx® (neratinib). According to the extended agreement, Pie...

Chiesi Group Plans to Invest €350m to Reduce Carbon Footprint of pMDI Inhalers

investments
Chiesi, the international research-focused healthcare Group (Chiesi Group), announces at the United Nations Climate Change Conference (COP25) its plan to bring to the market by the end of 2025 a break...

Boston Biomedical Entered into Alliance with World-Leading Oncology Centers

r&d
Boston Biomedical, Inc. announced that the company has entered into an alliance in oncology research with three world-leading oncology centers of excellence – Columbia University, Harvard University a...

US Senate Committee Advanced Nomination of Stephen Hahn to Lead FDA

fda
A Senate committee advanced the nomination of Dr. Stephen Hahn, a noted oncologist and cancer researcher, to lead the Food and Drug Administration. Dr. Hahn, a chief medical executive at th...

Grünenthal and Mesoblast Agreed to Develop and Commercialise MPC-06-ID

Grünenthal, a global leader in pain management, and Mesoblast Limited, a world leader in allogeneic cellular medicines for inflammatory diseases, announced that they have entered into a strategic part...

Idorsia and Mochida Entered Exclusive License Agreement

agreement
Idorsia Ltd and Mochida Pharmaceutical Co., Ltd. announced that they have entered into an exclusive license agreement for the supply, co-development and co-marketing of daridorexant, Idorsia’s dual or...

EMA Agreed to Review Marketing Application for Amarin’s Vascepa

The European Medicines Agency (EMA) has agreed to review its marketing application for Amarin’s cardiovascular (CV) drug, Vascepa (icosapent ethyl). The regulatory organisation says that it is expe...

Subscribe to GMP news Newsletter!

Interview

Team of Sechenov University Scientists to Make Presentation at the IFAA 2019 Congress in London

A team of Sechenov University scientists will present their research on the future of artificial intelligence in anatomy at the annual Congress of the International Federation of Associations of Anato...

SID&GP about MoU and Relatioship with UK

On January 29, the UK and Russia have signed a memorandum of understanding enhancing cooperation in the field of regulation of medicines. Radio Sputnik discussed the development with Nikolay Tsatsy...

InterPharm Technology Group®. Exceeding the expectations over 20 years

For 20 years, InterPharmTechnology Group® holds a prominent position in the market of pharmaceutical technological equipment in Russia and other EAEU member states.

Dara Pharma: Modern Pharmaceutical Equipment from Spain

David Rarl
One of the key factors that ensure that the manufacturers of drugs comply with GMP standards, is the implementation of modern technological equipment in their production plants which will be subsequen...

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies